2017
DOI: 10.1073/pnas.1704259114
|View full text |Cite
|
Sign up to set email alerts
|

Severe viral respiratory infections in children with IFIH1 loss-of-function mutations

Abstract: Viral respiratory infections are usually mild and self-limiting; still they exceptionally result in life-threatening infections in previously healthy children. To investigate a potential genetic cause, we recruited 120 previously healthy children requiring support in intensive care because of a severe illness caused by a respiratory virus. Using exome and transcriptome sequencing, we identified and characterized three rare loss-of-function variants in IFIH1, which encodes an RIG-I-like receptor involved in the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
127
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 118 publications
(136 citation statements)
references
References 44 publications
4
127
0
1
Order By: Relevance
“…However, contrary to published reports, we observed several episodes of severe viral infections in one patient, suggesting the possibility that JAK inhibitors might significantly increase the risk of infections possibly in cases of more severe lung involvement or in the presence of genetic modifiers, not investigated in our patient, with consequent deterioration of t he lung disease. Interestingly, the most frequent virus isolated was rhinovirus, which may be a direct consequence of effective type I IFN inhibition by ruxolitinib at least in respiratory epithelial cells, where IFN-β is required to control rhinovirus [16,17]. On the other end, these infections might result from a cumulative effect of the drug with the reported developmental and in vitro proliferative defects of STING mutant T lymphocytes [18,19].…”
Section: Discussionmentioning
confidence: 99%
“…However, contrary to published reports, we observed several episodes of severe viral infections in one patient, suggesting the possibility that JAK inhibitors might significantly increase the risk of infections possibly in cases of more severe lung involvement or in the presence of genetic modifiers, not investigated in our patient, with consequent deterioration of t he lung disease. Interestingly, the most frequent virus isolated was rhinovirus, which may be a direct consequence of effective type I IFN inhibition by ruxolitinib at least in respiratory epithelial cells, where IFN-β is required to control rhinovirus [16,17]. On the other end, these infections might result from a cumulative effect of the drug with the reported developmental and in vitro proliferative defects of STING mutant T lymphocytes [18,19].…”
Section: Discussionmentioning
confidence: 99%
“…Immunodeficiency has been linked to severe viral respiratory infections. Additional associations include TLR4 mutations with severe RSV bronchiolitis [8], IFIH1 loss-of-function mutations (which prevent sensing of viral RNA) with severe RNA virus (RSV and human rhinovirus) infections [9], and IRF7 [10] and IRF 9 [11] with severe influenza pneumonitis. All these genes are involved in innate immunity and interferon pathways and have been implicated in a theory proposing that monogenic inborn errors of immunity underlie susceptibility to specific infections [12].…”
Section: Discussionmentioning
confidence: 99%
“…We also identified a novel association of the IFIH1 loss-of-function allele rs1990760-C (p.T946A) with risk of asthma. The rs1990760-C allele, which protects against autoimmune diseases and increases risk of ulcerative colitis, has been shown to decrease interferon (IFN) signaling and lower resistance to viral challenge 40 , while complete loss-of IFIH1 function makes children susceptible to severe viral respiratory infections 41,42 . The association of rs1990760-C with increased risk of asthma discovered in our meta-PheWAS is consistent with the observation that bronchial epithelial cells from asthmatics produce lower amounts of IFN-β during viral infections 43 , a finding that lead to inhaled IFN-β being tested in phase 2 clinical trials for the treatment of virus-induced asthma exacerbation 44 .…”
Section: Discussionmentioning
confidence: 99%